Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Depreciation & Amortization (CF) (2022 - 2026)

Updated

Impact Biomedical (IBO) reported Depreciation & Amortization (CF) of $284,000 for Q3 2026, down 1.4% from $288,000 a year earlier and unchanged from the prior quarter.

Analysis

Impact Biomedical (IBO) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Impact Biomedical's Depreciation & Amortization (CF) came in at $1.14 million, up 0.1% year-over-year; for FY2025, it came in at $1.15 million, up 2.3% from FY2024.

  • Depreciation & Amortization (CF) has a three-year compound annual growth rate of 0.9% (FY2022 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $1.12 million in FY2024 (-0.1%), $1.12 million in FY2023 (+0.6%) and $1.11 million in FY2022.
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $278,000 in Q4 2022 and a high of $288,000 in Q3 2025.
  • Year over year, Depreciation & Amortization (CF) gained in five of the last eight quarters, with growth averaging 0.9%.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2025 (growth of 3.2%); the low point was Q2 2026 (a decline of 1.4%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $284,000 (Q2 2026), $285,000 (Q1 2026) and $286,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.12 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 192.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.58 Bn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 284,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 284,000.00
Jun 30, 2026 284,000.00
Mar 31, 2026 285,000.00
Dec 31, 2025 286,000.00
Sep 30, 2025 288,000.00
Jun 30, 2025 288,000.00
Mar 31, 2025 283,000.00
Dec 31, 2024 279,000.00
Sep 30, 2024 281,000.00
Jun 30, 2024 279,000.00
Mar 31, 2024 280,000.00
Dec 31, 2023 280,000.00
Sep 30, 2023 280,000.00
Jun 30, 2023 280,000.00
Mar 31, 2023 280,000.00
Dec 31, 2022 278,000.00
Sep 30, 2022 279,000.00
API Access

Impact Biomedical Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IBO&period=max&api_key=YOUR_API_KEY